Artal Group S.A. Roivant Sciences Ltd. Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$9.76 - $13.19 $6.1 Million - $8.24 Million
-625,000 Reduced 38.46%
1,000,000 $11.7 Million
Q2 2023

Aug 11, 2023
BUY
$7.09 - $10.08 $7.27 Million - $10.3 Million
1,025,000 Added 170.83%
1,625,000 $16.4 Million
Q1 2023

May 12, 2023
BUY
$6.92 - $9.98 $4.15 Million - $5.99 Million
600,000 New
600,000 $4.43 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.94B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email